B
TEVA icon

Bailard’s Teva Pharmaceuticals TEVA Stock Holding History

Bailard’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-180,200
Closed -$3.02M – 873
2025
Q2 		$3.02M Sell
180,200
-130,000
-42% -$2.1M 0.07% 189
2025
Q1 		$4.77M Buy
310,200
+200
+0.1% +$3.57K 0.12% 133
2024
Q4 		$6.83M Buy
+310,000
New +$5.64M 0.17% 116
2020
Q3 		– Sell
-332,000
Closed -$4.09M – 615
2020
Q2 		$4.09M Buy
+332,000
New +$3.75M 0.23% 89
2019
Q2 		– Sell
-360,495
Closed -$5.65M – 602
2019
Q1 		$5.65M Sell
360,495
-36,005
-9% -$635K 0.35% 64
2018
Q4 		$6.11M Buy
396,500
+26,800
+7% +$549K 0.41% 56
2018
Q3 		$7.96M Buy
+369,700
New +$8.58M 0.47% 44
2016
Q4 		– Sell
-80,361
Closed -$3.7M – 325
2016
Q3 		$3.7M Sell
80,361
-80,045
-50% -$4.18M 0.34% 73
2016
Q2 		$8.06M Sell
160,406
-54,894
-25% -$2.92M 0.96% 16
2016
Q1 		$11.5M Buy
215,300
+65,300
+44% +$3.83M 1.61% 12
2015
Q4 		$9.85M Sell
150,000
-65,300
-30% -$4.04M 4.33% 1
2015
Q3 		$12.2M Sell
215,300
-35,000
-14% -$2.27M 1.9% 10
2015
Q2 		$14.8M Hold
250,300
– – 2.29% 7
2015
Q1 		$15.6M Hold
250,300
– – 2.16% 7
2014
Q4 		$14.4M Buy
250,300
+70,000
+39% +$3.9M 2.03% 7
2014
Q3 		$9.69M Buy
180,300
+110,100
+157% +$5.83M 1.49% 9
2014
Q2 		$3.68M Buy
+70,200
New +$3.59M 0.57% 27

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bailard's TEVA Position: Q3 2025 in Review

Bailard sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 180,200 shares — an estimated $3.02M sold.

Bailard first reported a position in TEVA in Q2 2014 and held it in 17 quarters. The position peaked at $15.6M in Q1 2015. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Bailard reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Bailard sold 180,200 Teva Pharmaceuticals shares in Q3 2025, an estimated $3.02M.
  • Bailard first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 17 quarters.
  • Bailard's Teva Pharmaceuticals position peaked at $15.6M in Q1 2015.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Bailard's 13F filing for Q3 2025, filed 30 Oct 2025.